Hung-Jen Tang
About
Hung-Jen Tang is a scholar working on Epidemiology, Molecular Medicine and Infectious Diseases.
According to data from OpenAlex, Hung-Jen Tang has authored 68 papers receiving a total of 5.9k indexed citations (citations by other indexed papers that have themselves been cited), including 32 papers in Epidemiology, 31 papers in Molecular Medicine and 26 papers in Infectious Diseases. Recurrent topics in Hung-Jen Tang's work include Antibiotic Resistance in Bacteria (31 papers), Antibiotics Pharmacokinetics and Efficacy (16 papers) and Antimicrobial Resistance in Staphylococcus (11 papers). Hung-Jen Tang is often cited by papers focused on Antibiotic Resistance in Bacteria (31 papers), Antibiotics Pharmacokinetics and Efficacy (16 papers) and Antimicrobial Resistance in Staphylococcus (11 papers). Hung-Jen Tang collaborates with scholars based in Taiwan, United States and China. Hung-Jen Tang's co-authors include Wen‐Chien Ko, Po‐Ren Hsueh, Chih‐Cheng Lai, Yin-Ching Chuang, Chi-Chung Chen, Han Siong Toh, Wen‐Liang Yu, Ching‐Chi Lee, Yung-Ching Liu and Po‐Liang Lu and has published in prestigious journals such as PLoS ONE, Scientific Reports and Antimicrobial Agents and Chemotherapy.
In The Last Decade
Hung-Jen Tang
67 papers receiving 5.7k citations
Hit Papers
Peers — A (Enhanced Table)
Peers by citation overlap · career bar shows stage (early→late) cites · hero ref
| Name | h | Career | Trend | Papers | Cites | |||||
|---|---|---|---|---|---|---|---|---|---|---|
| Hung-Jen Tang Taiwan | 29 | 2.4k | 805 | 695 | 692 | 677 | 68 | 5.9k | ||
| Nancy A. Chow United States | 18 | 2.3k 1.0× | 1.1k 1.4× | 482 0.7× | 622 0.9× | 507 0.7× | 50 | 4.5k | ||
| Ali A. Rabaan Saudi Arabia | 43 | 3.1k 1.3× | 1.1k 1.3× | 559 0.8× | 314 0.5× | 564 0.8× | 308 | 7.7k | ||
| Charles W. Stratton United States | 43 | 3.9k 1.6× | 2.2k 2.8× | 988 1.4× | 389 0.6× | 476 0.7× | 260 | 8.9k | ||
| Preeti Malani United States | 39 | 2.5k 1.0× | 2.2k 2.7× | 310 0.4× | 541 0.8× | 275 0.4× | 196 | 8.0k | ||
| Abdullah M. Assiri Saudi Arabia | 41 | 4.6k 2.0× | 1.3k 1.6× | 223 0.3× | 444 0.6× | 1.5k 2.2× | 156 | 7.5k | ||
| Chih‐Cheng Lai Taiwan | 44 | 4.7k 2.0× | 2.9k 3.6× | 919 1.3× | 1.0k 1.5× | 818 1.2× | 444 | 12.0k | ||
| Sotirios Tsiodras Greece | 50 | 4.1k 1.7× | 2.3k 2.9× | 574 0.8× | 403 0.6× | 514 0.8× | 316 | 9.7k | ||
| Li Yang Hsu Singapore | 46 | 2.6k 1.1× | 1.5k 1.9× | 2.0k 2.9× | 363 0.5× | 584 0.9× | 199 | 8.2k | ||
| Myoung‐don Oh South Korea | 53 | 6.1k 2.6× | 3.1k 3.9× | 1.7k 2.4× | 548 0.8× | 736 1.1× | 337 | 11.7k | ||
| Esam I. Azhar Saudi Arabia | 42 | 4.4k 1.9× | 1.1k 1.4× | 393 0.6× | 184 0.3× | 786 1.2× | 357 | 9.5k |
Countries citing papers authored by Hung-Jen Tang
Since
Specialization
Citations
This map shows the geographic impact of Hung-Jen Tang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hung-Jen Tang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hung-Jen Tang more than expected).
Fields of papers citing papers by Hung-Jen Tang
Since
Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences
This network shows the impact of papers produced by Hung-Jen Tang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hung-Jen Tang. The network helps show where Hung-Jen Tang may publish in the future.
Co-authorship network of co-authors of Hung-Jen Tang
This figure shows the co-authorship network connecting the top 25 collaborators of Hung-Jen Tang. A scholar is included among the top collaborators of Hung-Jen Tang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hung-Jen Tang. Hung-Jen Tang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
1.
Tsai, Ya‐Wen, et al.. (2024). Post-pandemic epidemiological trends of respiratory infectious diseases in Taiwan: A retrospective analysis. Journal of Microbiology Immunology and Infection. 58(2). 233–240.
2.
Li, Ming-Chi, Hung-Jen Tang, Chi-Jung Wu, et al.. (2021). Species identification and antifungal susceptibility of uncommon blood yeast isolates. Journal of Microbiology Immunology and Infection. 55(1). 130–137.
3.
Lai, Chih‐Cheng, et al.. (2020). Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and coronavirus disease-2019 (COVID-19): The epidemic and the challenges. International Journal of Antimicrobial Agents. 55(3). 105924–105924.
4.
Chan, Khee-Siang, Fu‐Wen Liang, Hung-Jen Tang, Han Siong Toh, & Wen‐Liang Yu. (2020). Collateral benefits on other respiratory infections during fighting COVID-19. Medicina Clínica. 155(6). 249–253.
5.
Lai, Chih‐Cheng, Nan–Yao Lee, Hung-Jen Tang, et al.. (2019). <p>Susceptibility rates of clinically important bacteria collected from intensive care units against colistin, carbapenems, and other comparative agents: results from the Surveillance of Multicenter Antimicrobial Resistance in Taiwan (SMART)</p>. Infection and Drug Resistance. Volume 12. 627–640.
6.
Lee, Ching‐Chi, et al.. (2019). Definitive Cefazolin Treatment for Community-Onset Enterobacteriaceae Bacteremia Based on the Contemporary CLSI Breakpoint: Clinical Experience of a Medical Center in Southern Taiwan. Antibiotics. 8(4). 216–216.
7.
Liao, Chun‐Hsing, Hung-Jen Tang, Susan Shin‐Jung Lee, et al.. (2019). <p>Antimicrobial activities of ceftazidime–avibactam, ceftolozane–tazobactam, and other agents against <em>Escherichia coli</em>, <em>Klebsiella pneumoniae</em>, and <em>Pseudomonas aeruginosa</em> isolated from intensive care units in Taiwan: results from the Surveillance of Multicenter Antimicrobial Resistance in Taiwan in 2016</p>. Infection and Drug Resistance. Volume 12. 545–552.
8.
Toh, Han Siong, Shihchen Kuo, Hung-Jen Tang, et al.. (2019). Reduced economic burden of AIDS-defining illnesses associated with adherence to antiretroviral therapy. International Journal of Infectious Diseases. 91. 44–49.
9.
Lee, Ching‐Chi, Chih-Chia Hsieh, Ming‐Yuan Hong, et al.. (2019). Short versus long duration antimicrobial treatment for community-onset bacteraemia: A propensity score matching study. International Journal of Antimicrobial Agents. 54(2). 176–183.
10.
Tang, Hung-Jen, Susan Shin‐Jung Lee, Jen‐Chieh Lee, et al.. (2019). Determining the clinical characteristics and prognostic factors for the outcomes of Japanese encephalitis in adults: A multicenter study from southern Taiwan. Journal of Microbiology Immunology and Infection. 52(6). 893–901.
11.
Tang, Hung-Jen, Yuan‐Pin Hung, Po‐Lin Chen, et al.. (2018). Bloodstream infections in hospitalized adults with dengue fever: Clinical characteristics and recommended empirical therapy. Journal of Microbiology Immunology and Infection. 52(2). 225–232.
12.
Jean, Shio‐Shin, Nan–Yao Lee, Hung-Jen Tang, et al.. (2018). Carbapenem-Resistant Enterobacteriaceae Infections: Taiwan Aspects. Frontiers in Microbiology. 9. 2888–2888.
13.
Lee, Ching‐Chi, Jiun‐Ling Wang, Chung-Hsun Lee, et al.. (2017). Clinical benefits of antimicrobial de-escalation in adults with community-onset monomicrobial Escherichia coli , Klebsiella species and Proteus mirabilis bacteremia. International Journal of Antimicrobial Agents. 50(3). 371–376.
14.
Chen, Chi-Chung, et al.. (2017). Comparison of synergism between colistin, fosfomycin and tigecycline against extended-spectrum β-lactamase-producing Klebsiella pneumoniae isolates or with carbapenem resistance. Journal of Microbiology Immunology and Infection. 50(6). 931–939.
15.
Yu, Wen‐Liang, Mei-Feng Lee, Chi-Chung Chen, et al.. (2016). Impacts of Hypervirulence Determinants on Clinical Features and Outcomes of Bacteremia Caused by Extended-Spectrum β-Lactamase-Producing Klebsiella pneumoniae. Microbial Drug Resistance. 23(3). 376–383.
16.
Tang, Hung-Jen, et al.. (2015). In Vitro Activity of Imipenem and Colistin against a Carbapenem-ResistantKlebsiella pneumoniaeIsolate Coproducing SHV-31, CMY-2, and DHA-1. BioMed Research International. 2015. 1–5.
17.
Huang, Szu‐Wei, Sheng‐Fan Wang, Marcelo Chen, et al.. (2015). Molecular Epidemiology of HIV-1 Infection among Men who Have Sex with Men in Taiwan in 2012. PLoS ONE. 10(6). e0128266–e0128266.
18.
Yu, Wen‐Liang, et al.. (2015). Low prevalence of rmpA and high tendency of rmpA mutation correspond to low virulence of extended spectrum β-lactamase-producing klebsiella pneumoniae isolates. Virulence. 6(2). 162–172.
19.
Lu, Po‐Liang, Yung-Ching Liu, Han Siong Toh, et al.. (2012). Epidemiology and antimicrobial susceptibility profiles of Gram-negative bacteria causing urinary tract infections in the Asia-Pacific region: 2009–2010 results from the Study for Monitoring Antimicrobial Resistance Trends (SMART). International Journal of Antimicrobial Agents. 40. S37–S43.
20.
Chiang, Shyh-Ren, Yin-Ching Chuang, Hung-Jen Tang, et al.. (2009). Intratracheal colistin sulfate for BALB/c mice with early pneumonia caused by carbapenem-resistant Acinetobacter baumannii. Critical Care Medicine. 37(9). 2590–2595.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.
Explore authors with similar magnitude of impact
Breakdown of academic impact, for papers by Nancy A. Chow Breakdown of academic impact, for papers by Ali A. Rabaan Breakdown of academic impact, for papers by Charles W. Stratton Breakdown of academic impact, for papers by Preeti Malani Breakdown of academic impact, for papers by Abdullah M. Assiri Breakdown of academic impact, for papers by Chih‐Cheng Lai Breakdown of academic impact, for papers by Sotirios Tsiodras Breakdown of academic impact, for papers by Li Yang Hsu Breakdown of academic impact, for papers by Myoung‐don Oh Breakdown of academic impact, for papers by Esam I. Azhar